Status:
COMPLETED
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Acute Undifferentiated Leukemia
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
Eligibility:
All Genders
Up to 30 years
Brief Summary
This study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer. Collecting and storing samples of tumor tissue, blood, a...
Detailed Description
OBJECTIVES: I. Collect malignant, borderline malignant neoplasms, and related biological specimens from Children's Oncology Group institutions for cases in which there is no disease-specific biologic...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Meets any of the following criteria:
- Diagnosed with primary neoplasm
- Developed a second malignant neoplasm
- Any diagnoses having an ICD-O Morphology Code ending in 1, 2, or 3 as listed in the International Classification of Disease for Oncology, Third Edition
- Must have biological specimens including solid tumors and leukemias available
- Solid tumors meeting the following criteria:
- Snap frozen primary tumor OR OCT embedded primary tumor OR formalin fixed (block or tissue in formalin) primary tumor AND at least 10 unstained paraffin slides for NIH Mandated QC (tumors that have undergone central pathology review are allowed)
- Slides for pathology review (instead of slides for QC) are required for patients with rare tumors
- Pleural fluid or cytologic specimens meeting the following criteria:
- At least 1 mL of fluid and at least 2 unstained cytospin slides (or 2 unstained smears)
- Slides for pathology review (instead of slides for QC) are required for patients with rare tumors
- ALL/AML
- 3-6 mL of bone marrow aspirate and 10 mL of whole blood
- Not eligible for disease-specific biology or banking protocol
Exclusion
Key Trial Info
Start Date :
October 13 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
2545 Patients enrolled
Trial Details
Trial ID
NCT00898079
Start Date
October 13 2003
End Date
June 30 2018
Last Update
July 19 2018
Active Locations (192)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Alabama
Birmingham, Alabama, United States, 35233
2
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States, 35233
3
Phoenix Childrens Hospital
Phoenix, Arizona, United States, 85016
4
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202-3591